Colleen Tupper - Feb 10, 2023 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Signature
/s/ Colleen Tupper
Stock symbol
COLL
Transactions as of
Feb 10, 2023
Transactions value $
-$290,345
Form type
4
Date filed
2/14/2023, 04:17 PM
Previous filing
Oct 6, 2022
Next filing
Mar 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Award $0 +45K +49.88% $0.00 135K Feb 10, 2023 Direct F1
transaction COLL Common Stock Award +12.6K +9.28% 148K Feb 10, 2023 Direct F2
transaction COLL Common Stock Tax liability -$186K -6.97K -4.71% $26.75 141K Feb 10, 2023 Direct F3
transaction COLL Common Stock Tax liability -$104K -3.89K -2.76% $26.75 137K Feb 10, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
F2 Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 12,565 performance share units granted in the issuer's three prior fiscal years.
F3 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F4 Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units.